Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.
about
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model.Regulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsyLevetiracetam reverses synaptic deficits produced by overexpression of SV2AA double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patientsAnticonvulsant drugs and hematological disease.Cotrafficking of SV2 and synaptotagmin at the synapse.SV2 regulates neurotransmitter release via multiple mechanisms.The EULEV cohort study: rates of and factors associated with continuation of levetiracetam after 1 year.Psychiatric symptoms and quality of life in patients with drug-refractory epilepsy receiving adjunctive levetiracetam therapyLevetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis.Role of intravenous levetiracetam in seizure prophylaxis of severe traumatic brain injury patients.Prospects of levetiracetam as a neuroprotective drug against status epilepticus, traumatic brain injury, and strokeLevetiracetam: a comprehensive review.Levetiracetam-induced leukocytoclastic vasculitis.Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited.Review of Levetiracetam as a First Line Treatment in Status Epilepticus in the Adult Patients - What Do We Know so Far?An 11-year review of levetiracetam ingestions in children less than 6 years of age.Abbreviated levetiracetam treatment effects on behavioural and histological outcomes after experimental TBI.Levetiracetam-induced pancytopenia.Levitating levetiracetam's status for status epilepticus.Safety of non-therapeutic levetiracetam ingestions--a poison center based study.B cell aplasia and hypogammaglobulinemia associated with levetiracetam.Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs.Levetiracetam ameliorates ovarian function in streptozotocin-induced diabetic rats.A meta-analysis of randomized controlled trials on levetiracetam in the treatment of pediatric patients with epilepsy.
P2860
Q24624879-8B4DADAD-6E58-462E-9B01-012D895741A2Q26859135-A4270A20-EB48-44A2-9BE4-9A5E8F39D969Q28478633-76CC35AE-BDE0-4E82-BFDA-A60B216865F6Q30417813-76E3C206-5C64-444A-BC0D-3EDD69E9BDE4Q33413868-5D7ABB0A-D231-40C5-B4A0-B3CAD964ED45Q33835261-DE17C3E8-6A94-4CC1-9CC2-DD27A891724AQ34304904-9788BAC4-3921-4DEE-8CC1-0A3384BB7844Q34476131-27562B72-6580-41BA-83E5-D5C813421150Q35539645-CB381386-5B11-47DE-A583-D394FD6795C1Q36072176-A8A5E1C1-ECBD-4D0C-B150-CB4352DE021FQ37271469-50FB42C3-68EA-4AE5-97B1-724A0E9DE6CBQ37276387-2986B61C-CCDD-4967-84E6-466D8D07916EQ37688063-8AA08540-FE93-4671-ACC5-633F15DB9E7FQ37700997-FC9EFC77-083F-4EE1-8E92-4391E09B6C05Q37823314-B07EB6B5-58AF-4E7E-B12E-29FF0622C47FQ38128294-B15C7E7F-1C6E-40D5-855D-34EA1F1FA8BCQ38256797-F72C8173-3298-44E2-9B4B-C751C54F9425Q39123432-D7FA39A9-BADB-4DCF-90E4-139EB03C3D2EQ41996164-5746AC51-D262-4C73-92CA-25F2E7EB8821Q42148938-79BDA283-867E-4857-85FD-043B21AEC5DBQ45182191-B4B24D1C-3A18-4850-8950-5248323A611CQ47556435-89E13CBD-A910-4C07-BE72-9C407B254959Q48190757-5393E9AD-0D62-4700-A0D9-F19A4BAEC1BAQ50993769-37649BDA-5900-4A21-BB46-1B40F3D41AD6Q51737526-6835006D-F276-43F4-ABB0-BF91BF47CE7E
P2860
Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.
@ast
Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.
@en
type
label
Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.
@ast
Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.
@en
prefLabel
Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.
@ast
Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.
@en
P2093
P2860
P1476
Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.
@en
P2093
Kristl Vonck
Robrecht Raedt
Tim De Smedt
P2860
P356
10.1111/J.1527-3458.2007.00005.X
P50
P577
2007-01-01T00:00:00Z